American Century Companies Inc Ovid Therapeutics Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.85 - $2.26 $50,375 - $61,539	-27,230 Reduced 73.0%	10,071 $19,000
Q2 2022 Aug 12, 2022	SELL	$1.69 - $3.31 $33,080 - $64,789	-19,574 Reduced 34.42%	37,301 $80,000
Q1 2022 May 11, 2022	BUY	$2.65 - $3.49 $26,484 - $34,879	9,994 Added 21.32%	56,875 $179,000
Q4 2021 Feb 07, 2022	BUY	$3.13 - $3.73 $28,263 - $33,681	9,030 Added 23.86%	46,881 $150,000
Q3 2021 Nov 10, 2021	BUY	$3.31 - $4.04 $125,286 - $152,918	37,851 New	37,851 $127,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.